NextGen : Oncomine Myeloid Panel (69 Gene)
Guaranteed Safe Checkout
NextGen : Oncomine Myeloid Panel (69 Gene)
Gain comprehensive insights into blood cancers with the NextGen: Oncomine Myeloid Panel (69 Gene) at Lucid Medical Diagnostics. This advanced Next-Generation Sequencing (NGS) test analyzes 69 clinically significant genes associated with myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). Our cutting-edge molecular oncology testing, genetic profiling, and precision medicine diagnostics provide accurate, reliable, and timely results to support diagnosis, prognosis, and targeted treatment decisions. Trust Lucid Medical Diagnostics for expert cancer genetic testing and advanced laboratory services.
Home Sample Collection Available
Get Reports
